CD94-NKG2A receptors regulate antiviral CD8+ T cell responses
10.1038/ni757
Crossref journal-article
Springer Science and Business Media LLC
Nature Immunology (297)
Bibliography

Moser, J. M., Gibbs, J., Jensen, P. E., & Lukacher, A. E. (2002). CD94-NKG2A receptors regulate antiviral CD8+ T cell responses. Nature Immunology, 3(2), 189–195.

Authors 4
  1. Janice M. Moser (first)
  2. James Gibbs (additional)
  3. Peter E. Jensen (additional)
  4. Aron E. Lukacher (additional)
References 47 Referenced 170
  1. Bergmann, C. C., Altman, J. D., Hinton, D. & Stohlman, S. A. Inverted immunodominance and impaired cytolytic function of CD8+ T cells during viral persistence in the central nervous system. J. Immunol. 163, 3379–3387 (1999). (10.4049/jimmunol.163.6.3379) / J. Immunol. by CC Bergmann (1999)
  2. Lukacher, A. E., Moser, J. M., Hadley, A. & Altman, J. D. Visualization of polyoma virus-specific CD8+ T cells in vivo during infection and tumor rejection. J. Immunol. 163, 3369–3378 (1999). (10.4049/jimmunol.163.6.3369) / J. Immunol. by AE Lukacher (1999)
  3. Murali-Krishna, K. et al. Counting antigen-specific CD8 T cells: a reevaluation of bystander activation during viral infection. Immunity 8, 177–187 (1998). (10.1016/S1074-7613(00)80470-7) / Immunity by K Murali-Krishna (1998)
  4. Lanier, L. L. Face off–the interplay between activating and inhibitory immune receptors. Curr. Opin. Immunol. 13, 326–331 (2001). (10.1016/S0952-7915(00)00222-3) / Curr. Opin. Immunol. by LL Lanier (2001)
  5. McMahon, C. W. & Raulet, D. H. Expression and function of NK cell receptors in CD8+ T cells. Curr. Opin. Immunol. 13, 465–470 (2001). (10.1016/S0952-7915(00)00242-9) / Curr. Opin. Immunol. by CW McMahon (2001)
  6. Raulet, D. H., Vance, R. E. & McMahon, C. W. Regulation of the natural killer cell receptor repertoire. Annu. Rev. Immunol. 19, 291–330 (2001). (10.1146/annurev.immunol.19.1.291) / Annu. Rev. Immunol. by DH Raulet (2001)
  7. Braud, V. M. et al. HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C. Nature 391, 795–799 (1998). (10.1038/35869) / Nature by VM Braud (1998)
  8. Vance, R. E., Kraft, J. R., Altman, J. D., Jensen, P. E. & Raulet, D. H. Mouse CD94/NKG2A is a natural killer cell receptor for the nonclassical major histocompatibility complex (MHC) class I molecule Qa-1b. J. Exp. Med. 188, 1841–1848 (1998). (10.1084/jem.188.10.1841) / J. Exp. Med. by RE Vance (1998)
  9. Carretero, M. et al. Specific engagement of the CD94/NKG2-A killer inhibitory receptor by the HLA-E class Ib molecule induces SHP-1 phosphatase recruitment to tyrosine-phosphorylated NKG2-A: evidence for receptor function in heterologous transfectants. Eur. J. Immunol. 28, 1280–1291 (1998). (10.1002/(SICI)1521-4141(199804)28:04<1280::AID-IMMU1280>3.0.CO;2-O) / Eur. J. Immunol. by M Carretero (1998)
  10. Le Drean, E. et al. Inhibition of antigen-induced T cell response and antibody-induced NK cell cytotoxicity by NKG2A: association of NKG2A with SHP-1 and SHP-2 protein-tyrosine phosphatases. Eur. J. Immunol. 28, 264–276 (1998). (10.1002/(SICI)1521-4141(199801)28:01<264::AID-IMMU264>3.0.CO;2-O) / Eur. J. Immunol. by E Le Drean (1998)
  11. Ugolini, S. & Vivier, E. Regulation of T cell function by NK cell receptors for classical MHC class I molecules. Curr. Opin. Immunol. 12, 295–300 (2000). (10.1016/S0952-7915(00)00090-X) / Curr. Opin. Immunol. by S Ugolini (2000)
  12. Mingari, M. C. et al. Human CD8+ T lymphocyte subsets that express HLA class I-specific inhibitory receptors represent oligoclonally or monoclonally expanded cell populations. Proc. Natl Acad. Sci. USA 93, 12433–12438 (1996). (10.1073/pnas.93.22.12433) / Proc. Natl Acad. Sci. USA by MC Mingari (1996)
  13. De Maria, A. et al. Expression of HLA class I-specific inhibitory natural killer cell receptors in HIV-specific cytolytic T lymphocytes: impairment of specific cytolytic functions. Proc. Natl Acad. Sci. USA 94, 10285–10288 (1997). (10.1073/pnas.94.19.10285) / Proc. Natl Acad. Sci. USA by A De Maria (1997)
  14. Zajac, A. J. et al. Impaired anti-viral T cell responses due to expression of the Ly49A inhibitory receptor. J. Immunol. 163, 5526–5534 (1999). (10.4049/jimmunol.163.10.5526) / J. Immunol. by AJ Zajac (1999)
  15. Brawand, P., Lemonnier, F. A., MacDonald, H. R., Cerottini, J. C. & Held, W. Transgenic expression of Ly49A on T cells impairs a specific antitumor response. J. Immunol. 165, 1871–1876 (2000). (10.4049/jimmunol.165.4.1871) / J. Immunol. by P Brawand (2000)
  16. Coles, M. C., McMahon, C. W., Takizawa, H. & Raulet, D. H. Memory CD8 T lymphocytes express inhibitory MHC-specific Ly49 receptors. Eur. J. Immunol. 30, 236–244 (2000). (10.1002/1521-4141(200001)30:1<236::AID-IMMU236>3.0.CO;2-X) / Eur. J. Immunol. by MC Coles (2000)
  17. Vetter, C. S. et al. Expression of CD94/NKG2 subtypes on tumor-infiltrating lymphocytes in primary and metastatic melanoma. J. Invest. Dermatol. 114, 941–947 (2000). (10.1046/j.1523-1747.2000.00958.x) / J. Invest. Dermatol. by CS Vetter (2000)
  18. Speiser, D. E. et al. In vivo expression of natural killer cell inhibitory receptors by human melanoma-specific cytolytic T lymphocytes. J. Exp. Med. 190, 775–782 (1999). (10.1084/jem.190.6.775) / J. Exp. Med. by DE Speiser (1999)
  19. Moser, J. M., Altman, J. D. & Lukacher, A. E. Antiviral CD8+ T cell responses in neonatal mice: susceptibility to polyoma virus-induced tumors is associated with lack of cytotoxic function by viral antigen-specific T cells. J. Exp. Med. 193, 595–605 (2001). (10.1084/jem.193.5.595) / J. Exp. Med. by JM Moser (2001)
  20. Vance, R. E., Jamieson, A. M. & Raulet, D. H. Recognition of the class Ib molecule Qa-1b by putative activating receptors CD94/NKG2C and CD94/NKG2E on mouse natural killer cells. J. Exp. Med. 190, 1801–1812 (1999). (10.1084/jem.190.12.1801) / J. Exp. Med. by RE Vance (1999)
  21. Slifka, M. K. & Whitton, J. L. Functional avidity maturation of CD8+ T cells without selection of higher affinity TCR. Nature Immunol. 2, 711–717 (2001). (10.1038/90650) / Nature Immunol. by MK Slifka (2001)
  22. Kraft, J. R. et al. Analysis of Qa-1b peptide binding specificity and the capacity of CD94/NKG2A to discriminate between Qa-1–peptide complexes. J. Exp. Med. 192, 613–624 (2000). (10.1084/jem.192.5.613) / J. Exp. Med. by JR Kraft (2000)
  23. Lukacher, A. E., Freund, R., Carroll, J. P., Bronson, R. T. & Benjamin, T. L. PyvS: a dominantly acting gene in C3H/BiDa mice conferring susceptibility to tumor induction by polyoma virus. Virology 196, 241–248 (1993). (10.1006/viro.1993.1472) / Virology by AE Lukacher (1993)
  24. Drake III, D. R. & Lukacher, A. E. b2-microglobulin knockout mice are highly susceptible to polyoma virus tumorigenesis. Virology 252, 275–284 (1998). (10.1006/viro.1998.9455) / Virology by DR Drake III (1998)
  25. Kaech, S. M. & Ahmed, R. Memory CD8+ T cell differentiation: initial antigen encounter triggers a developmental program in naive cells. Nature Immunol. 2, 415–422 (2001). (10.1038/87720) / Nature Immunol. by SM Kaech (2001)
  26. Wong, P. & Pamer, E. G. Cutting edge: antigen-independent CD8 T cell proliferation. J. Immunol. 166, 5864–5868 (2001). (10.4049/jimmunol.166.10.5864) / J. Immunol. by P Wong (2001)
  27. Lukacher, A. E. et al. Susceptibility to tumors induced by polyoma virus is conferred by an endogenous mouse mammary tumor virus superantigen. J. Exp. Med. 181, 1683–1692 (1995). (10.1084/jem.181.5.1683) / J. Exp. Med. by AE Lukacher (1995)
  28. Huard, B. & Karlsson, L. KIR expression on self-reactive CD8+ T cells is controlled by T-cell receptor engagement. Nature 403, 325–328 (2000). (10.1038/35002105) / Nature by B Huard (2000)
  29. Mingari, M. C., Moretta, A. & Moretta, L. Regulation of KIR expression in human T cells: a safety mechanism that may impair protective T-cell responses. Immunol. Today 19, 153–157 (1998). (10.1016/S0167-5699(97)01236-X) / Immunol. Today by MC Mingari (1998)
  30. Ahmad, A., Sharif-Askari, E., Fawaz, L. & Menezes, J. Innate immune response of the human host to exposure with herpes simplex virus type 1: in vitro control of the virus infection by enhanced natural killer activity via interleukin-15 induction. J. Virol. 74, 7196–7203 (2000). (10.1128/JVI.74.16.7196-7203.2000) / J. Virol. by A Ahmad (2000)
  31. Azimi, N., Tagaya, Y., Mariner, J. & Waldmann, T. A. Viral activation of interleukin-15 (IL-15): characterization of a virus- inducible element in the IL-15 promoter region. J. Virol. 74, 7338–7348 (2000). (10.1128/JVI.74.16.7338-7348.2000) / J. Virol. by N Azimi (2000)
  32. Wirth, J. J., Martin, L. G. & Fluck, M. M. Oncogenesis of mammary glands, skin, and bones by polyomavirus correlates with viral persistence and prolonged genome replication potential. J. Virol. 71, 1072–1078 (1997). (10.1128/jvi.71.2.1072-1078.1997) / J. Virol. by JJ Wirth (1997)
  33. Voehringer, D. et al. Viral infections induce abundant numbers of senescent CD8 T cells. J. Immunol. 167, 4838–4843 (2001). (10.4049/jimmunol.167.9.4838) / J. Immunol. by D Voehringer (2001)
  34. Transy, C. et al. A low polymorphic mouse H-2 class I gene from the Tla complex is expressed in a broad variety of cell types. J. Exp. Med. 166, 341–361 (1987). (10.1084/jem.166.2.341) / J. Exp. Med. by C Transy (1987)
  35. Chun, T. et al. Constitutive and regulated expression of the class IB molecule Qa-1 in pancreatic β cells. Immunology 94, 64–71 (1998). (10.1046/j.1365-2567.1998.00475.x) / Immunology by T Chun (1998)
  36. Cerboni, C. et al. Synergistic effect of IFN-g and human cytomegalovirus protein UL40 in the HLA-E-dependent protection from NK cell-mediated cytotoxicity. Eur. J. Immunol. 31, 2926–2935 (2001). (10.1002/1521-4141(2001010)31:10<2926::AID-IMMU2926>3.0.CO;2-2) / Eur. J. Immunol. by C Cerboni (2001)
  37. Biron, C. A. Interferons α and β as immune regulators–a new look. Immunity 14, 661–664 (2001). (10.1016/S1074-7613(01)00154-6) / Immunity by CA Biron (2001)
  38. Gross, L. G. in Oncogenic Viruses, 3rd edn 737–828 (Pergamon, Oxford, 1983). / Oncogenic Viruses by LG Gross (1983)
  39. Freund, R., Sotkinov, A., Bronson, R. T. & Benjamin, T. L. Polyoma virus middle T is essential for virus replication and persistence as well as for tumor induction in mice. Virology 191, 716–723 (1992). (10.1016/0042-6822(92)90247-M) / Virology by R Freund (1992)
  40. Roger, J., Chalifour, A., Lemieux, S. & Duplay, P. Ly49A inhibits TCR/CD3-induced apoptosis and IL-2 secretion. J. Immunol. 167, 6–10 (2001). (10.4049/jimmunol.167.1.6) / J. Immunol. by J Roger (2001)
  41. Ugolini, S. et al. Involvement of inhibitory NKRs in the survival of a subset of memory- phenotype CD8+ T cells. Nature Immunol. 2, 430–435 (2001). (10.1038/87740) / Nature Immunol. by S Ugolini (2001)
  42. Welsh, R. M. Assessing CD8 T cell number and dysfunction in the presence of antigen. J. Exp. Med. 193, F19–F22 (2001). (10.1084/jem.193.5.F19) / J. Exp. Med. by RM Welsh (2001)
  43. Lukacher, A. E. & Wilson, C. S. Resistance to polyoma virus-induced tumors correlates with CTL recognition of an immunodominant H-2Dk-restricted epitope in the middle T protein. J. Immunol. 160, 1724–1734 (1998). (10.4049/jimmunol.160.4.1724) / J. Immunol. by AE Lukacher (1998)
  44. van der Most, R. G. et al. Analysis of cytotoxic T cell responses to dominant and subdominant epitopes during acute and chronic lymphocytic choriomeningitis virus infection. J. Immunol. 157, 5543–5554 (1996). (10.4049/jimmunol.157.12.5543) / J. Immunol. by RG van der Most (1996)
  45. Deng, Y., Yewdell, J. W., Eisenlohr, L. C. & Bennink, J. R. MHC affinity, peptide liberation, T cell repertoire, and immunodominance all contribute to the paucity of MHC class I-restricted peptides recognized by antiviral CTL. J. Immunol. 158, 1507–1515 (1997). (10.4049/jimmunol.158.4.1507) / J. Immunol. by Y Deng (1997)
  46. van der Most, R. G. et al. Identification of Db- and Kb-restricted subdominant cytotoxic T-cell responses in lymphocytic choriomeningitis virus-infected mice. Virology 240, 158–167 (1998). (10.1006/viro.1997.8934) / Virology by RG van der Most (1998)
  47. Ward, P. L., Koeppen, H., Hurteau, T. & Schreiber, H. Tumor antigens defined by cloned immunological probes are highly polymorphic and are not detected on autologous normal cells. J. Exp. Med. 170, 217–232 (1989). (10.1084/jem.170.1.217) / J. Exp. Med. by PL Ward (1989)
Dates
Type When
Created 23 years, 1 month ago (July 26, 2002, 4:30 a.m.)
Deposited 4 months, 2 weeks ago (April 10, 2025, 8:55 a.m.)
Indexed 3 weeks, 1 day ago (Aug. 6, 2025, 8 a.m.)
Issued 23 years, 7 months ago (Jan. 22, 2002)
Published 23 years, 7 months ago (Jan. 22, 2002)
Published Online 23 years, 7 months ago (Jan. 22, 2002)
Published Print 23 years, 6 months ago (Feb. 1, 2002)
Funders 0

None

@article{Moser_2002, title={CD94-NKG2A receptors regulate antiviral CD8+ T cell responses}, volume={3}, ISSN={1529-2916}, url={http://dx.doi.org/10.1038/ni757}, DOI={10.1038/ni757}, number={2}, journal={Nature Immunology}, publisher={Springer Science and Business Media LLC}, author={Moser, Janice M. and Gibbs, James and Jensen, Peter E. and Lukacher, Aron E.}, year={2002}, month=jan, pages={189–195} }